S. Brækkan

发表

Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study

J. Hansen, E. Mathiesen, I. Njølstad, 2010, Journal of thrombosis and haemostasis : JTH.

Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population

J. Hansen, S. Brækkan, N. Arshad, 2017, European Journal of Epidemiology.

Prothrombotic genotypes and risk of venous thromboembolism in cancer.

J. Hansen, S. Brækkan, O. V. Gran, 2018, Thrombosis research.

Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism

K. Frazer, Erin N. Smith, J. Hansen, 2016, Haematologica.

The increased risk of venous thromboembolism by advancing age cannot be attributed to the higher incidence of cancer in the elderly: the Tromsø study

S. Cessie, J. Hansen, S. Cannegieter, 2014, European Journal of Epidemiology.

Hematocrit and risk of venous thromboembolism in a general population. The Tromsø study

J. Hansen, E. Mathiesen, I. Njølstad, 2010, Haematologica.

Associations between serum levels of calcium, parathyroid hormone and future risk of venous thromboembolism: the Tromsø study.

J. Hansen, J. Svartberg, R. Jorde, 2017, European journal of endocrinology.

C‐reactive protein, obesity, and the risk of arterial and venous thrombosis

J. Hansen, E. Mathiesen, I. Njølstad, 2016, Journal of thrombosis and haemostasis : JTH.

High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromsø study

J. Hansen, E. Mathiesen, I. Njølstad, 2011, Haematologica.

Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.

J. Manson, A. Folsom, K. Overvad, 2017, Circulation.

association of traditional cardiovascular risk Factors With Venous thromboembolism an individual Participant Data

J. Manson, A. Folsom, K. Overvad, 2016 .

Hyperglycemia , Assessed by HbA 1 c , and Future Risk of Venous Thromboembolism-The Tromsø Study Running head : HbA 1 c and VTE

J. Hansen, I. Njølstad, J. Svartberg, 2015 .

Coffee consumption and the risk of venous thromboembolism: the Tromsø study

J. Hansen, T. Wilsgaard, S. Brækkan, 2011, Journal of thrombosis and haemostasis : JTH.

COPD and risk of venous thromboembolism and mortality in a general population

J. Hansen, H. Schirmer, S. Brækkan, 2015, European Respiratory Journal.

Serum osteoprotegerin and renal function in the general population: the Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2016, Clinical kidney journal.

Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function – the Tromsø study

J. Hansen, S. Brækkan, J. Brox, 2012, Haematologica.

Serum levels of vitamin D are not associated with future risk of venous thromboembolism

J. Hansen, J. Svartberg, R. Jorde, 2013, Thrombosis and Haemostasis.

D-dimer as a stand-alone test to rule out deep vein thrombosis.

J. Hansen, S. Brækkan, W. Ghanima, 2020, Thrombosis research.

Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study

J. Hansen, S. Brækkan, H. Jensvoll, 2014, PloS one.

Postprandial lipemia is not increased in patients with previous unprovoked venous thromboembolism.

J. Hansen, S. Brækkan, E. Brodin, 2013, Journal of clinical lipidology.

Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study.

J. Hansen, S. Brækkan, E. Brodin, 2012, Thrombosis research.

Body Height and Risk of Venous Thromboembolism

J. Hansen, E. Mathiesen, K. Borch, 2010 .

Emotional states and future risk of venous thromboembolism

J. Hansen, S. Brækkan, K. Enga, 2012, Thrombosis and Haemostasis.

Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study

E. Mathiesen, K. Borch, I. Njølstad, 2009, Journal of thrombosis and haemostasis : JTH.

Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study

J. Hansen, E. Mathiesen, B. Jacobsen, 2018, Nutrition Journal.

Cigarette smoking and the risk of venous thromboembolism: The Tromsø Study

S. Cessie, S. le Cessie, J. Hansen, 2012, Journal of thrombosis and haemostasis : JTH.

Weight Change and Risk of Venous Thromboembolism: The Tromsø Study

J. Hansen, S. Brækkan, L. D. Horvei, 2016, PloS one.

Obesity measures and risk of venous thromboembolism and myocardial infarction

J. Hansen, E. Mathiesen, I. Njølstad, 2014, European Journal of Epidemiology.

Alcohol consumption, types of alcoholic beverages and risk of venous thromboembolism – The Tromsø Study

T. Wilsgaard, S. Brækkan, J. Hansen, 2011 .

High fish plus fish oil intake is associated with slightly reduced risk of venous thromboembolism: the Tromsø Study.

J. Hansen, E. Mathiesen, I. Njølstad, 2014, The Journal of nutrition.

Elevated plasma levels of P‐selectin glycoprotein ligand‐1‐positive microvesicles in patients with unprovoked venous thromboembolism

S. Brækkan, J. Hansen, M. G. Basavaraj, 2018, Journal of thrombosis and haemostasis : JTH.

Dietary Intake of Marine Polyunsaturated n-3 Fatty Acids and Risk of Recurrent Venous Thromboembolism

J. Hansen, S. Brækkan, L. H. Evensen, 2019, Thrombosis and Haemostasis.

Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism—the Tromsø study

J. Hansen, S. Brækkan, H. Melbye, 2020, Research and practice in thrombosis and haemostasis.

Venous thromboembolism and subsequent permanent work‐related disability

J. Hansen, S. Krokstad, J. Tsai, 2016, Journal of thrombosis and haemostasis : JTH.

The venous thrombosis registry in Østfold Hospital (TROLL registry) ‐ design and cohort description

S. Brækkan, M. Tavoly, J. Gleditsch, 2022, Research and practice in thrombosis and haemostasis.

Dietary intake of marine n‐3 polyunsaturated fatty acids and future risk of venous thromboembolism

J. Hansen, B. Jacobsen, S. Johnsen, 2018, Research and practice in thrombosis and haemostasis.

Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death

E. Horváth-Puhó, H. Sørensen, J. Hansen, 2021, European Journal of Epidemiology.

Thyroid function, assessed by thyroid stimulating hormone, and future risk of venous thromboembolism -The Tromsø study

J. Hansen, J. Svartberg, R. Jorde, 2016 .

Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort

A. Tjønneland, K. Overvad, J. Hansen, 2015, Clinical epidemiology.

Thyroid function, as assessed by TSH, and future risk of venous thromboembolism: the Tromsø study.

J. Hansen, J. Svartberg, R. Jorde, 2015, European journal of endocrinology.

Original Contribution Body Height and Risk of Venous Thromboembolism

J. Hansen, E. Mathiesen, K. Borch, 2010 .

High Levels of Complement Activating Enzyme MASP-2 Are Associated With the Risk of Future Incident Venous Thromboembolism

J. Hansen, P. Garred, O. Snir, 2022, Arteriosclerosis, thrombosis, and vascular biology.

HDL‐cholesterol and future risk of venous thromboembolism: the Tromsø Study

E. Mathiesen, K. Borch, S. Brækkan, 2009, Journal of thrombosis and haemostasis : JTH.

Impact of preanalytical conditions on plasma concentration and size distribution of extracellular vesicles using Nanoparticle Tracking Analysis

J. Hansen, P. Webster, S. Brækkan, 2018, Scientific Reports.

Substantial recurrence risk after venous thromboembolism provoked by minor risk factors

S. Brækkan, J. Hansen, 2018, Journal of thrombosis and haemostasis : JTH.

Impact of red cell distribution width on future risk of cancer and all-cause mortality among cancer patients – the Tromsø Study

J. Hansen, S. Brækkan, T. Skjelbakken, 2015, Haematologica.

Genetic variation of platelet glycoprotein VI and the risk of venous thromboembolism

J. Hansen, F. Rosendaal, K. Hveem, 2019, Haematologica.

Hand grip strength and risk of incident venous thromboembolism: The Tromsø study

J. Hansen, B. Strand, S. Brækkan, 2022, Research and practice in thrombosis and haemostasis.

Red cell distribution width is associated with future risk of incident stroke

J. Hansen, E. Mathiesen, I. Njølstad, 2015, Thrombosis and Haemostasis.

Family History of Myocardial Infarction and Cause-Specific Risk of Myocardial Infarction and Venous Thromboembolism: The Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2014, Circulation. Cardiovascular genetics.

Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study

J. Hansen, E. Mathiesen, I. Njølstad, 2008, Journal of thrombosis and haemostasis : JTH.

Role of microRNAs in Venous Thromboembolism

J. Hansen, S. Brækkan, V. Morelli, 2020, International journal of molecular sciences.

Effective filtering strategies to improve data quality from population-based whole exome sequencing studies

Hiroko Matsui, Kristen Jepsen, Kelly A. Frazer, 2014, BMC Bioinformatics.

Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study

K. Frazer, Erin N. Smith, J. Hansen, 2019, Journal of thrombosis and haemostasis : JTH.

Red Cell Distribution Width Is Associated With Incident Myocardial Infarction in a General Population: The Tromsø Study

E. Barrett-Connor, J. Hansen, E. Mathiesen, 2014, Journal of the American Heart Association.

C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study

J. Hansen, S. Brækkan, J. Brox, 2018, Haematologica.

Myocardial infarction and future risk of cancer in the general population—the Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2017, European Journal of Epidemiology.

Plasma hepcidin is associated with future risk of venous thromboembolism.

J. Hansen, T. Ueland, P. Aukrust, 2018, Blood advances.

White Blood Cell Count Measured Prior to Cancer Development Is Associated with Future Risk of Venous Thromboembolism – The Tromsø Study

Sigrid K. Brækkan, John-Bjarne Hansen, J. Hansen, 2013, PloS one.

The risk of venous thromboembolism attributed to established prothrombotic genotypes

J. Hansen, F. Rosendaal, K. Hveem, 2021, Thrombosis and Haemostasis.

Impact of a Vancomycin-Induced Shift of the Gut Microbiome in a Gram-Negative Direction on Plasma Factor VIII:C Levels: Results from a Randomized Controlled Trial

J. Hansen, M. Nieuwdorp, T. Ueland, 2021, Thrombosis and Haemostasis.

Chronic Obstructive Pulmonary Disease and Risk of Mortality in Patients with Venous Thromboembolism—The Tromsø Study

J. Hansen, S. Brækkan, H. Melbye, 2019, Thrombosis and Haemostasis.

Red cell distribution width and carotid atherosclerosis progression The Tromsø Study

J. Hansen, E. Mathiesen, S. Johnsen, 2015, Thrombosis and Haemostasis.

Hyperglycemia, assessed according to HbA1c, and future risk of venous thromboembolism: the Tromsø study

J. Hansen, I. Njølstad, J. Svartberg, 2014, Journal of thrombosis and haemostasis : JTH.

Complement factors B, D, C3bBbP and risk of future venous thromboembolism.

J. Hansen, T. Ueland, O. Snir, 2023, Clinical immunology.

Association of smoking and cancer with the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer cohort

A. Tjønneland, K. Overvad, J. Hansen, 2021, Scientific Reports.

Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event

J. Hansen, F. Rosendaal, K. Hveem, 2020, Journal of Thrombosis and Haemostasis.

Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2020, Research and practice in thrombosis and haemostasis.

Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism

K. Frazer, Erin N. Smith, J. Hansen, 2019, Haematologica.

Cardiorespiratory fitness and future risk of venous thromboembolism

J. Hansen, S. Brækkan, T. Isaksen, 2019, Journal of thrombosis and haemostasis : JTH.

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding

J. Hansen, S. Brækkan, K. Hindberg, 2019, TH Open.

Regular Physical Activity and Risk of Venous Thromboembolism

J. Hansen, S. Brækkan, L. Evensen, 2018, Seminars in Thrombosis and Hemostasis.

Recurrence and mortality after first venous thromboembolism in a large population‐based cohort

J. Hansen, S. Brækkan, J. Hansen, 2017, Journal of thrombosis and haemostasis : JTH.

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2016, PloS one.

Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2016, Journal of thrombosis and haemostasis : JTH.

Impact of Incident Venous Thromboembolism on Risk of Arterial Thrombotic Diseases

K. Overvad, J. Hansen, E. Mathiesen, 2014, Circulation.

Carotid Atherosclerosis Predicts Future Myocardial Infarction But Not Venous Thromboembolism: The Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Joint Effects of Obesity and Body Height on the Risk of Venous Thromboembolism: The Tromsø Study

J. Hansen, E. Mathiesen, K. Borch, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Anthropometric Measures of Obesity and Risk of Venous Thromboembolism: The Tromsø Study

J. Hansen, E. Mathiesen, K. Borch, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study

E. Mathiesen, I. Njølstad, S. Johnsen, 2017, Journal of thrombosis and haemostasis : JTH.

The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer

J. Hansen, E. Mathiesen, I. Njølstad, 2018, Research and practice in thrombosis and haemostasis.

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2017, TH Open.

Statin use and risk of recurrent venous thrombosis: results from the MEGA follow‐up study

S. le Cessie, F. Rosendaal, S. Cannegieter, 2017, Research and practice in thrombosis and haemostasis.

Competing Risk of Atherosclerotic Risk Factors for Arterial and Venous Thrombosis in a General Population: The Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2012, Arteriosclerosis, thrombosis, and vascular biology.

Cardiovascular risk factors and risk of venous thromboembolism

S. Brækkan, 2010 .

Plasma procoagulant phospholipid clotting time and venous thromboembolism risk

J. Hansen, O. Snir, S. Brækkan, 2021, Research and practice in thrombosis and haemostasis.

Plasma levels of mannose‐binding lectin and future risk of venous thromboembolism

J. Hansen, T. Ueland, P. Aukrust, 2019, Journal of thrombosis and haemostasis : JTH.

Complement activation assessed by the plasma terminal complement complex and future risk of venous thromboembolism

J. Hansen, T. Ueland, O. Snir, 2019, Journal of thrombosis and haemostasis : JTH.

Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2018, TH Open.

VTE epidemiology and challenges for VTE prevention at the population level

J. Hansen, S. Brækkan, 2023, Thrombosis Update.

Risk of a permanent work-related disability pension after incident venous thromboembolism in Denmark: A population-based cohort study

E. Horváth-Puhó, H. Sørensen, J. Hansen, 2021, PLoS medicine.

D‐dimer at venous thrombosis diagnosis is associated with risk of recurrence

S. Brækkan, J. Hansen, H. S. Johnsen, 2017, Journal of thrombosis and haemostasis : JTH.

S. Brækkan, J. Hansen, N. Arshad, 2016, Journal of thrombosis and haemostasis : JTH.

Acute infection as a trigger for incident venous thromboembolism: Results from a population‐based case‐crossover study

J. Hansen, S. Brækkan, T. Isaksen, 2017, Research and practice in thrombosis and haemostasis.

Hospitalization as a trigger for venous thromboembolism - Results from a population-based case-crossover study.

J. Hansen, S. Brækkan, H. S. Johnsen, 2019, Thrombosis research.

The Role of Stroke as a Trigger for Incident Venous Thromboembolism: Results from a Population-based Case-Crossover Study

J. Hansen, S. Brækkan, K. Hindberg, 2019, TH Open.

Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population

J. Hansen, S. Brækkan, T. Skjelbakken, 2014, Thrombosis and Haemostasis.

Association of Mild to Moderate Chronic Kidney Disease With Venous Thromboembolism: Pooled Analysis of Five Prospective General Population Cohorts

A. Folsom, B. Astor, J. Coresh, 2012, Circulation.

Atrial Fibrillation and Cause‐Specific Risks of Pulmonary Embolism and Ischemic Stroke

J. Hansen, E. Mathiesen, I. Njølstad, 2018, Journal of the American Heart Association.

Atrial Fibrillation and Cause-Speci fi c Risks of Pulmonary Embolism and Ischemic Stroke

Inger, J. Hansen, E. Mathiesen, 2018 .

Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.

J. Hansen, T. Ueland, P. Aukrust, 2021, Thrombosis research.

Plasma Levels of Leptin and Risk of Future Incident Venous Thromboembolism

J. Hansen, T. Ueland, P. Aukrust, 2021, Thrombosis and Haemostasis.

Joint Effect of Multiple Prothrombotic Genotypes and Obesity on the Risk of Incident Venous Thromboembolism

J. Hansen, K. Hveem, B. Brumpton, 2021, Thrombosis and Haemostasis.

Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.

J. Hansen, T. Ueland, P. Aukrust, 2021, Blood advances.

Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism.

J. Hansen, T. Ueland, P. Aukrust, 2020, Blood.

Impact of time since diagnosis and mortality rate on cancer‐associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort

A. Tjønneland, K. Overvad, J. Hansen, 2018, Journal of thrombosis and haemostasis : JTH.

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort

A. Tjønneland, K. Overvad, J. Hansen, 2018, TH Open.

Neutrophil to lymphocyte ratio and future risk of venous thromboembolism and mortality: the Tromsø Study

J. Hansen, S. Brækkan, L. D. Horvei, 2016, Haematologica.

Impact of preanalytical conditions on plasma concentration and size distribution of extracellular vesicles using Nanoparticle Tracking Analysis

J. Hansen, P. Webster, S. Brækkan, 2018, Scientific Reports.

Myocardial Infarction as a Transient Risk Factor for Incident Venous Thromboembolism: Results from a Population-Based Case–Crossover Study

J. Hansen, S. Brækkan, K. Hindberg, 2019, Thrombosis and Haemostasis.

Occult cancer‐related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism

J. Hansen, F. Rosendaal, S. Brækkan, 2017, Journal of thrombosis and haemostasis : JTH.

Serum osteoprotegerin and future risk of cancer and cancer-related mortality in the general population: the Tromsø study

J. Hansen, E. Mathiesen, I. Njølstad, 2015, European Journal of Epidemiology.

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study

J. Hansen, E. Mathiesen, I. Njølstad, 2020, Research and practice in thrombosis and haemostasis.

Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort.

A. Tjønneland, K. Overvad, J. Hansen, 2017, Thrombosis research.

F. Rosendaal, B. Hansen, S. Brækkan, 2017 .

Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2020, TH Open.

Combined effects of plasma von Willebrand factor and platelet measures on the risk of incident venous thromboembolism.

J. Hansen, T. Ueland, P. Aukrust, 2021, Blood.

Alcohol consumption, types of alcoholic beverages and risk of venous thromboembolism – The Tromsø Study

J. Hansen, T. Wilsgaard, S. Brækkan, 2011, Thrombosis and Haemostasis.

C1 inhibitor deficiency enhances contact pathway mediated activation of coagulation and venous thrombosis.

J. Hansen, N. Mackman, K. McCrae, 2023, Blood.

Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study

K. Frazer, F. Rosendaal, S. Brækkan, 2018, Journal of thrombosis and haemostasis : JTH.

Monocyte count and procoagulant functions are associated with risk of venous thromboembolism: the Tromsø study

S. Brækkan, J. Hansen, B. Østerud, 2011, Journal of thrombosis and haemostasis : JTH.

Diagnostic Blood Biomarkers for Acute Pulmonary Embolism: A Systematic Review

J. Hansen, S. Brækkan, V. Morelli, 2023, Diagnostics.

D-dimer measured at first venous thromboembolism is associated with future risk of cancer

J. Hansen, S. Brækkan, O. V. Gran, 2016, Haematologica.

Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study

A. Tjønneland, K. Overvad, J. Hansen, 2023, Blood advances.

Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics

K. Frazer, J. Hansen, S. Braekkan, 2018, Journal of thrombosis and haemostasis : JTH.

Association of Mild to Moderate Chronic Kidney Disease With Venous Thromboembolism: Pooled Analysis of Five Prospective General Population Cohorts

A. Folsom, B. Astor, J. Hansen, 2012, Circulation.

The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort

A. Tjønneland, K. Overvad, S. Braekkan, 2017, Journal of thrombosis and haemostasis : JTH.

Joint effect of multiple prothrombotic genotypes and mean platelet volume on the risk of incident venous thromboembolism.

J. Hansen, S. Brækkan, Tobias Frischmuth, 2022, Thrombosis and haemostasis.

Hand grip strength in venous thromboembolism: risk of recurrence and mortality

J. Hansen, S. Brækkan, V. Morelli, 2023, Research and practice in thrombosis and haemostasis.

Obesity and risk of bleeding: the SMART study.

A. Algra, S. Braekkan, F. Visseren, 2016, Journal of thrombosis and haemostasis : JTH.

Surgery As a Trigger for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study

J. Hansen, S. Brækkan, V. Morelli, 2023, TH Open.

Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2016, Journal of the American Heart Association.

Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism

K. Frazer, Erin N. Smith, J. Hansen, 2016, Haematologica.

Prothrombotic genotypes and risk of venous thromboembolism in cancer.

J. Hansen, S. Brækkan, O. V. Gran, 2018, Thrombosis research.

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort

A. Tjønneland, K. Overvad, J. Hansen, 2018, TH Open.

Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.

J. Manson, A. Folsom, K. Overvad, 2017, Circulation.

Association of Mild to Moderate Chronic Kidney Disease With Venous Thromboembolism Pooled Analysis of Five Prospective General Population Cohorts

A. Folsom, R. Gansevoort, K. Matsushita, 2012 .

Association of Mild to Moderate Chronic Kidney Disease With Venous Thromboembolism Pooled Analysis of Five Prospective General Population Cohorts

A. Folsom, R. Gansevoort, K. Matsushita, 2012 .

Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function – the Tromsø study

J. Hansen, S. Brækkan, J. Brox, 2012, Haematologica.

Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study

J. Hansen, E. Mathiesen, I. Njølstad, 2008, Journal of thrombosis and haemostasis : JTH.

Joint effect of multiple prothrombotic genotypes and obesity on the risk of incident venous thromboembolism Running head: Genotypes, obesity and venous thromboembolism

B. Brumpton, S. Brækkan, K. Hindberg, 2022 .

Repeated assessments of physical activity and risk of incident venous thromboembolism

S. Braekkan, S. Brækkan, J. Hansen, 2018, Journal of thrombosis and haemostasis : JTH.

COPD and risk of venous thromboembolism and mortality in a general population

J. Hansen, H. Schirmer, S. Brækkan, 2015, European Respiratory Journal.

Dietary intake of marine n‐3 polyunsaturated fatty acids and future risk of venous thromboembolism

J. Hansen, B. Jacobsen, S. Johnsen, 2018, Research and practice in thrombosis and haemostasis.

Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study

E. Mathiesen, S. Braekkan, I. Njølstad, 2015, Journal of thrombosis and haemostasis : JTH.

Venous thromboembolism and risk of depression: a population-based cohort study.

E. Horváth-Puhó, J. Hansen, S. Brækkan, 2022, Journal of thrombosis and haemostasis : JTH.

Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.

A. Tjønneland, J. Hansen, K. Hveem, 2021, Thrombosis research.

Prothrombotic genotypes and risk of major bleeding in patients with incident venous thromboembolism.

J. Hansen, S. Brækkan, K. Hindberg, 2020, Thrombosis research.